Evogene Ltd (EVGN)

Etorro trading 970x250
Evogene Ltd (EVGN) Logo

About Evogene Ltd

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Application segment develops enhanced castor bean seeds to serve as a feedstock source for biofuel and other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and multi drug resistant organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7612002

Evogene Ltd News and around…

Latest news about Evogene Ltd (EVGN) common stock and company :

Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug
27 Oct, 2021 Yahoo! Finance

Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and Rambam Health Care Campus today announced the signing of a clinical trial agreement (CTA) for initiating a first in-human proof-of-concept (POC) for BMC128, Biomica's drug candidate.

Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021
27 Oct, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the third quarter of 2021 on Wednesday, November 17th, 2021. Dr. Arnon Heyman, CEO of Canonic Ltd., Evogene's subsidiary, will be joining the conference call.

Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of Schedule
19 Oct, 2021 FinancialContent

Evogene Ltd.'s (NASDAQ: EVGN) (TASE: EVGN) wholly-owned subsidiary focused on developing medical cannabis products, Canonic Ltd., ...

Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in Israel
19 Oct, 2021 Yahoo! Finance

Canonic Ltd., focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced the full commercial launch of its first two medical cannabis products, known as G200 and G150, following positive feedback received from patients during the company's pre-launch campaign. These products were originally expected to be released to market during 2022.

Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021
08 Oct, 2021 FinancialContent

Upgrades UBS upgraded the previous rating for Northern Trust Corp (NASDAQ:NTRS) from Neutral to Buy. Northern Trust earned $1.79 in ...

Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio's Inoculant Product
29 Sep, 2021 Yahoo! Finance

Lavie Bio Ltd. (Lavie), a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, and United Agronomy (UA), a full-service retailer of crop inputs, including seeds, inoculants, fertilizers, and chemicals, announce today that they have entered into a distribution agreement, initially for spring wheat, for LAV.211, a Lavie deve

Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021
14 Sep, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational predictive biology company aiming to revolutionize life-science product development acros\s several market segments, announced today that Mr. Ofer Haviv, Evogene's President and CEO, will be interviewed in a "Fireside Chat" at the Cantor Virtual Global Healthcare Conference taking place on September 27-30, 2021. Mr. Haviv's interview will focus on Evogene's disruptive technologies; its tailor-made engines for product discovery and

What Makes Evogene (EVGN) a New Buy Stock
03 Sep, 2021 Yahoo! Finance

Evogene (EVGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

4 Robinhood Penny Stocks To Watch As ANY Stock Ignites Small Caps
02 Sep, 2021 FinancialContent
Evogene to Present at H.C. Wainwright 23rd Annual Global Investment Conference - 2021
01 Sep, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that Ofer Haviv, Evogene's President and CEO, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, 2021, taking place from September 9-15, 2021. Mr. Haviv's presentation will focus on Evogene's disruptive technologies, its tailor-made engines for product discovery and development and its

Canonic Announces Pre-Launch of Medical Cannabis Products in Israel
31 Aug, 2021 FinancialContent

Canonic Ltd, a company focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: ...

Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel
31 Aug, 2021 Yahoo! Finance

Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation medical cannabis inflorescence products.

The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More
13 Aug, 2021 FinancialContent

Below is a recap of the main news related to the cannabis industry and markets for the week of August 13, 2021, which was marked by ...

Evogene Reports $135.000 In Q2 2021 Revenue, Misses Estimates, EPS Beat Projections By $0.02
11 Aug, 2021 FinancialContent

Biotechnology company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) posted its financial results Wednesday for the first half and second ...

Evogene Reports Second Quarter 2021 Financial Results
11 Aug, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announced today its financial results for the first half and the second quarter of 2021, ended June 30, 2021.

Evogene to Present at Jefferies Virtual Industrials Conference, 2021
29 Jul, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that Ofer Haviv, Evogene's President and CEO, will present at the Jefferies Virtual Industrials Conference, 2021 taking place on August 3-4,2021. Mr. Haviv's presentation will focus on Evogene's disruptive technologies; its tailor-made engines for product discovery and development and its fields of activity thro

Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021
28 Jul, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the second quarter of 2021 on Wednesday, August 11th, 2021. Ms. Sarit Firon Evogene's incoming Chairperson of the Board, will join the conference call to discuss her vision for Evogene.

Best Penny Stocks To Buy Before Marijuana Legalization? 4 To Watch Now
13 Jul, 2021 FinancialContent
Top Robinhood Penny Stocks to Buy? 7 For Your Mid-July Watchlist
08 Jul, 2021 FinancialContent
AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate
06 Jul, 2021 Yahoo! Finance

AgPlenus Ltd., a company designing effective, sustainable crop protection products by leveraging computational biology and chemistry, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has achieved positive results in a Proof of Concept (POC) testing of a resistance trait for its leading novel Mode-of-Action (MoA) herbicide product candidate, APH1.

Evogene Announces Ms. Sarit Firon to become Evogene's Chairperson of the Board
23 Jun, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that its Board of Directors has resolved to appoint Ms. Sarit Firon to serve as Chairperson of the Board following, and subject to, her re-election as a Director at Evogene's upcoming Annual General Meeting. Mr. Martin Gerstel, Evogene's current Chairperson, recently informed the Board that after almost two deca

Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings
26 May, 2021 FinancialContent

Computational biology company Evogene Ltd. (NASDAQ: EVGN) reported Wednesday its first-quarter financial results with revenue of ...

Evogene Reports First Quarter 2021 Financial Results
26 May, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announces today its financial results for the first quarter of 2021.

Earnings Scheduled For May 26, 2021
26 May, 2021 FinancialContent

Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is expected to report quarterly loss at $0.14 per share ...

Lavie Bio Announces the Appointment of Russ Putland as Vice President Commercial
25 May, 2021 Yahoo! Finance

Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced the appointment of Mr. Russ Putland as Vice President Commercial. Russ's significant commercial experience includes more than 30 years of leadership within large multinational agriculture companies. In his last leadership role, he led a sales organization at DuPont crop protection, accountable for $175 million in sales annually.

Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021
12 May, 2021 Yahoo! Finance

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2021 on Wednesday, May 26th, 2021. Mr. Ido Dor, Chief Executive Officer of Evogene's subsidiary, Lavie Bio Ltd., will join the conference call to discuss Lavie Bio's recent activity.

Biomica to Present at Jefferies Microbiome-Based Therapeutics Summit, on April 22nd, 2021
19 Apr, 2021 Yahoo! Finance

Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced that Dr. Elran Haber, Chief Executive Officer of Biomica, will present at the Jefferies Microbiome-Based Therapeutics Summit being held on Thursday, April 22, 2021.

Penny Stocks To Buy According To Analysts With Price Targets Up to 341%
18 Apr, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
13 Apr, 2021 FinancialContent

Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's ...

Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma
13 Apr, 2021 Yahoo! Finance

Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced additional positive pre-clinical results in its immuno-oncology program demonstrating efficacy of its live biotherapeutic product (LBP) consortium BMC128, this time in melanoma. In these studies, Biomica tested BMC128, which consists of four live bacterial strains, in a mouse model of melanoma.

Evogene Ltd (EVGN) is a NASDAQ Common Stock listed in , ,

970x250